Nabriva Therapeutics plc·4

Jan 10, 5:56 PM ET

Schroeder Theodore R 4

4 · Nabriva Therapeutics plc · Filed Jan 10, 2023

Insider Transaction Report

Form 4
Period: 2023-01-06
Schroeder Theodore R
Chief Executive Officer)
Transactions
  • Tax Payment

    Ordinary Shares

    2023-01-06$1.30/sh11$1412,420 total
Footnotes (1)
  • [F1]These ordinary shares were withheld by the Issuer in order to satisfy tax withholding obligations upon the vesting of certain restricted share units.

Documents

1 file
  • 4
    tm231658-4_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT